These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11590129)

  • 1. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
    Luiro K; Kopra O; Lehtovirta M; Jalanko A
    Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
    Järvelä I; Sainio M; Rantamäki T; Olkkonen VM; Carpén O; Peltonen L; Jalanko A
    Hum Mol Genet; 1998 Jan; 7(1):85-90. PubMed ID: 9384607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL).
    Järvelä I; Lehtovirta M; Tikkanen R; Kyttälä A; Jalanko A
    Hum Mol Genet; 1999 Jun; 8(6):1091-8. PubMed ID: 10332042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis.
    Oetjen S; Kuhl D; Hermey G
    J Neurochem; 2016 Nov; 139(3):456-470. PubMed ID: 27453211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Burkovetskaya M; Karpuk N; Kielian T
    Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
    Chan CH; Mitchison HM; Pearce DA
    Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease.
    Nelson T; Pearce DA; Kovács AD
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
    Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
    Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical localization of the Batten disease (CLN3) protein in retina.
    Katz ML; Gao CL; Prabhakaram M; Shibuya H; Liu PC; Johnson GS
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2375-86. PubMed ID: 9344361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis.
    Sappington RM; Pearce DA; Calkins DJ
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3725-31. PubMed ID: 12939285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells.
    Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE
    Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
    de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
    J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.